ProfileGDS4890 / 219232_s_at
TitleSystemic lupus erythematosus patients and yellow fever vaccine-immunized healthy donors: CD16+ monocytes
OrganismHomo sapiens


SLE 1 SLE 2 SLE 3 SLE 4 ND 55 ND 56 ND 57 systemic lupus erythematosus healthy not immunized before YFV immunization after YFV immunization before YFV immunization after YFV immunization before YFV immunization after YFV immunization GSM1256968 GSM1256969 GSM1256970 GSM1256971 GSM1256988 GSM1256991 GSM1256989 GSM1256992 GSM1256990 GSM1256993 49% 33% 41% 42% 5% 12% 45% 44% 49% 27% sort by individual sort by disease state sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1256968SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 113.606649
GSM1256969SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 26.559733
GSM1256970SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 39.9548541
GSM1256971SLE-patients; Group 3: CD16pos, resident monocytes; active SLE 411.166642
GSM1256988Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 55 before YFV0.7905165
GSM1256991Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 55 seven days after YFV1.5526212
GSM1256989Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 56 before YFV14.409245
GSM1256992Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 56 seven days after YFV11.653644
GSM1256990Yellow fever vaccinated NDs; Group 8: CD16pos, resident monocytes; ND 57 before YFV15.961249
GSM1256993Yellow fever vaccinated NDs; Group 9: CD16pos, resident monocytes; ND 57 seven days after YFV4.4146827